BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10155596)

  • 1. Overview of the lenograstim pharmacoeconomics programme.
    Oster G; Menzin J; Richard D; Cour-Chabernaud V
    Pharmacoeconomics; 1994; 6 Suppl 2():9-17. PubMed ID: 10155596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoeconomic evaluation of lenograstim. Conclusions and future directions.
    Menzin J; Oster G; Cour-Chabernaud V; Richard D
    Pharmacoeconomics; 1994; 6 Suppl 2():53-60. PubMed ID: 10155595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic analysis of lenograstim in the correction of neutropenia following chemotherapy for non-Hodgkin's lymphoma.
    Souêtre E; Qing W
    Pharmacoeconomics; 1994; 6 Suppl 2():36-43. PubMed ID: 10172484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodological issues in economic assessments of new therapies. The case of colony-stimulating factors.
    Drummond M; Menzin J; Oster G
    Pharmacoeconomics; 1994; 6 Suppl 2():18-26. PubMed ID: 10155592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of lenograstim for prophylaxis of chemotherapy-induced neutropenia in patients with small cell lung cancer.
    Drummond M; Davies L
    Pharmacoeconomics; 1994; 6 Suppl 2():44-52. PubMed ID: 10155594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of lenograstim (glycosylated rHuG-CSF) in the treatment of inflammatory breast cancer for Germany and Italy.
    Mapelli V; Graf vond der Schulenburg JM; Laaser U; Allhoff PG; Rossi F
    Pharmacoeconomics; 1994; 6 Suppl 2():27-35. PubMed ID: 10155593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lenograstim: an update of its pharmacological properties and use in chemotherapy-induced neutropenia and related clinical settings.
    Dunn CJ; Goa KL
    Drugs; 2000 Mar; 59(3):681-717. PubMed ID: 10776839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lenograstim on the cost of autologous bone marrow transplantation. A preliminary communication.
    Brice P; Godin S; Libert O; Marolleau JP; Makki J; Extra JM; Faure P; Gisselbrecht C
    Pharmacoeconomics; 1995 Mar; 7(3):238-41. PubMed ID: 10155313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lenograstim. A review of its pharmacological properties and therapeutic efficacy in neutropenia and related clinical settings.
    Frampton JE; Yarker YE; Goa KL
    Drugs; 1995 May; 49(5):767-93. PubMed ID: 7541335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical and biochemical characteristics of glycosylated recombinant human granulocyte colony stimulating factor (lenograstim).
    Ono M
    Eur J Cancer; 1994; 30A Suppl 3():S7-11. PubMed ID: 7535073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy dose intensity facilitated by use of lenograstim--implications for quality of life and survival.
    Gisselbrecht C
    Eur J Cancer; 1994; 30A Suppl 3():S30-3. PubMed ID: 7535070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose granulocyte colony-stimulating factor overcomes neutropenia in the treatment of non-Hodgkin's lymphoma with higher cost-effectiveness.
    Hara T; Tsurumi H; Kasahara S; Kanemura N; Yoshikawa T; Goto N; Kojima Y; Yamada T; Sawada M; Takahashi T; Oyama M; Tomita E; Moriwaki H
    Int J Hematol; 2005 Dec; 82(5):430-6. PubMed ID: 16533747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of available clinical evidence - filgrastim compared with lenograstim.
    Sourgens H; Lefrère F
    Int J Clin Pharmacol Ther; 2011 Aug; 49(8):510-8. PubMed ID: 21781651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
    Bhana N
    Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of glycosylated recombinant human granulocyte colony-stimulating factor (lenograstim) use in current cancer treatment: review of clinical data.
    Gunzer K; Clarisse B; Lheureux S; Delcambre C; Joly F
    Expert Opin Biol Ther; 2010 Apr; 10(4):615-30. PubMed ID: 20218922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factors used in clinical practice: PoloNord Registry-Based Cohort Italian Study.
    Fagnani D; Isa L; Verga MF; Nova P; Casartelli C; Filipazzi V; Danova M; Farina G; Pugliese P; Fava S; Bertolini A; Cimminiello C; Boracchi P; Marano G; Panzarino C;
    Tumori; 2014; 100(5):491-8. PubMed ID: 25343541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colony stimulating factors: G-CSFs--filgrastim (Neupogen) and lenograstim (Granocyte).
    MacConnachie AM
    Intensive Crit Care Nurs; 1998 Feb; 14(1):49-50. PubMed ID: 9652261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost benefit and clinical efficacy of low-dose granulocyte colony-stimulating factor after standard chemotherapy in patients with non-Hodgkin's lymphoma.
    Hashino S; Morioka M; Irie T; Shiroshita N; Kawamura T; Suzuki S; Iwasaki H; Umehara S; Kakinoki Y; Kurosawa M; Kahata K; Izumiyama K; Kobayashi H; Onozawa M; Takahata M; Fujisawa F; Kondo T; Asaka M
    Int J Lab Hematol; 2008 Aug; 30(4):292-9. PubMed ID: 18665826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized comparative observation of single- versus split-dose lenograstim to enhance engraftment after autologous stem cell transplantation in patients with multiple myeloma or non-Hodgkin's lymphoma.
    Jang G; Ko OB; Kim S; Lee DH; Huh J; Suh C
    Transfusion; 2008 Apr; 48(4):640-6. PubMed ID: 18194384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group.
    Dombret H; Chastang C; Fenaux P; Reiffers J; Bordessoule D; Bouabdallah R; Mandelli F; Ferrant A; Auzanneau G; Tilly H
    N Engl J Med; 1995 Jun; 332(25):1678-83. PubMed ID: 7539109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.